| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/09/2011 | CN101983663A Traditional Chinese medicine for treating diabetic nephropathy |
| 03/09/2011 | CN101983648A Traditional Chinese medicine for treating prostatic hyperplasia |
| 03/09/2011 | CN101983646A Traditional Chinese medicine composition for treating kidney deficiency and preparation method thereof |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 03/08/2011 | US7901874 Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or α1 type IV collagen |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2329054C A novel polypeptide hormone phosphatonin |
| 03/03/2011 | WO2011025968A1 1h-pyrazolo [ 3, 4-b] pyridine compounds for inhibiting raf kinase |
| 03/03/2011 | WO2011024955A1 Nucleic acid capable of binding to tgf-βii-type receptor, and use thereof |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024468A1 Novel sulfonamide derivative and pharmaceutical product containing same |
| 03/03/2011 | WO2011023986A1 Kinase inhibitors |
| 03/03/2011 | WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110053995 Benzenesulfonanilide compound inhibitors of urea transporters |
| 03/03/2011 | US20110053985 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2011 | US20110053984 Novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2011 | US20110053980 Indane-amine derivatives, their preparation and use as medicaments |
| 03/03/2011 | US20110053961 Substituted xanthine derivatives |
| 03/03/2011 | US20110053940 3,4-substituted piperidine derivatives as renin inhibitors |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 03/03/2011 | US20110053902 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 03/03/2011 | US20110052674 Angiotensin ii receptor blocker derivatives |
| 03/03/2011 | US20110052567 Methods Compositions, Uses, and Kits Useful for Vitamin D Deficiency and Related Disorders |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | CA2772316A1 1h-pyrazolo [3,4-b] pyridine compounds for inhibiting raf kinase |
| 03/03/2011 | CA2771992A1 Kinase inhibitors |
| 03/03/2011 | CA2769151A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289503A2 Treating muscle wasting with selective androgen receptor modulators |
| 03/02/2011 | EP2288337A1 Parenteral supplement with traceelem ntsfor treatment of i. a. sirs, burns selenium-defenciencies |
| 03/02/2011 | EP1389102B1 Use of lanthanum carbonate for the prevention of kidney stone disease |
| 03/02/2011 | CN101983207A Anti mif antibodies |
| 03/02/2011 | CN101983055A Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 03/02/2011 | CN101983054A Orally rapidly disintegrating tablet comprising imidafenacin |
| 03/02/2011 | CN101982184A Preparation method of taraxacum extract |
| 03/02/2011 | CN101433549B Use of nano selenium in preparing calcium oxalate crystallization inhibitor |
| 03/02/2011 | CN101352481B Method for preparing Chinese medicine desmodium anti-calculi fractionated extracts and uses thereof |
| 03/02/2011 | CN101301023B Pilose antler deer penis collagen polypeptide, and preparation and produced oral preparation thereof |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897617 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | US7897147 Treatment of premenstrual disorders |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2010132764A3 Live-attenuated compositions for bacterial infections |
| 02/24/2011 | US20110046482 Methods for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 02/24/2011 | US20110046179 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/24/2011 | US20110046166 Purine derivatives as a3 adenosine receptor-selective agonists |
| 02/24/2011 | US20110046164 Purine Derivatives for Treatment of Cystic Diseases |
| 02/24/2011 | US20110046136 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associcated therewith |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046087 Pharmaceutical composition, methods for treating and uses thereof |
| 02/24/2011 | US20110046062 Factor h for the treatment of chronic nephropathies and production thereof |
| 02/24/2011 | US20110045090 Formulations of flibanserin |
| 02/24/2011 | US20110045053 Isolated population of luminal stem cells that give rise to prostate cancer and methods of using same |
| 02/24/2011 | US20110045014 Acceleration agent of calcium absorption |
| 02/24/2011 | US20110044973 Treatment of cystic disease with lysophosphatidic acid antagonists |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2286820A1 Buffered Compositions for dialysis |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2285370A1 Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder. |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101981006A Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/23/2011 | CN101980705A Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979068A Medicament for treating urinary tract infection |
| 02/23/2011 | CN101979067A Traditional Chinese medicine for treating gonorrhoea |
| 02/23/2011 | CN101979062A Chinese medicament for treating diabetic nephropathy |
| 02/23/2011 | CN101979058A Chinese medicament for treating chronic nephritis |
| 02/23/2011 | CN101979037A Medicament for treating diabetic complications and preparation method thereof |
| 02/23/2011 | CN101979028A Traditional Chinese medicinal preparation for treating urolithiasis |
| 02/23/2011 | CN101979008A External traditional Chinese medicine bag for treating prostatic diseases |
| 02/23/2011 | CN101979004A Chinese medicament for treating benign prostatic hyperplasia |
| 02/23/2011 | CN101979000A Traditional Chinese medicinal prescription for quickly treating lithiasis |
| 02/23/2011 | CN101978982A Application of Japanese ginseng or extract thereof to preparation of medicament for resisting gout and repairing hyperuricemic kidney injury |
| 02/23/2011 | CN101978910A Snake bee nano-selenium element Chinese medicinal anion far infrared multi-functional navel-warming bag shorts |
| 02/23/2011 | CN101317972B Yilongbao soft capsule and preparation thereof |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893087 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/22/2011 | US7893042 Boc-glycyl-phenazopyridine; phenazopyridines covalently attached to various conjugates; useful for providing increased (oral) bioavailability with reduced side effects |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/17/2011 | WO2011019963A2 Prg4 treatment for interstitial cystitis |
| 02/17/2011 | WO2011019074A1 Nucleic acid that controls fibrosis of cells or organs |
| 02/17/2011 | WO2011018894A1 Pyrrolopyrimidine derivatives as potassium channel modulators |